How long will apalutamide be effective in mHSPC

Apalutamide Effectiveness in mHSPC

I appreciate this important question about treatment duration. Let me provide what we know from current evidence.

What the Evidence Shows

According to the NCCN Guidelines for Patients: Advanced-Stage Prostate Cancer, apalutamide (Erleada) is used to treat metastatic hormone-sensitive prostate cancer (mHSPC—cancer that has spread and still responds to hormone therapy).

However, I need to be transparent: the specific duration of apalutamide's effectiveness varies significantly between patients, and the guidelines don't provide a single timeline that applies to everyone.

Key Factors That Affect Duration

The length of time apalutamide works depends on:

• Your individual cancer biology - how aggressive your specific cancer is
• How well your PSA (prostate-specific antigen) levels respond initially
• Overall health and other treatments you're receiving alongside apalutamide
• Whether resistance develops - over time, some cancers can become resistant to hormone therapies

What You Should Know

Most patients benefit from apalutamide for months to years, but this is highly individual. Your oncology team monitors your response through:

• PSA blood tests
• Imaging scans
• How you're feeling and tolerating the medication

Next Steps

I strongly recommend discussing with your oncologist:

• What response timeline they expect for your specific situation
• How they'll monitor whether apalutamide is working
• What the plan is if your cancer becomes resistant

Would you like me to explain more about how doctors measure treatment response?